EUVIMEDEUVIMED entdecken
Crossref

Effectiveness and safety of Perampanel in refractory status epilepticus: a case series

Rosaria Renna, Vincenzo Andreone, Paolo Barone, Pietro Penza

Neurological Sciences · 2025

DOI: 10.1007/s10072-024-07798-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurological Sciences, 2025. Verfasst von Rosaria Renna und 3 weiteren Autor:innen. Beteiligte Einrichtung: Neurological Clinic and Stroke Unit, "A. Cardarelli" Hospital, Naples, Italy. rosrenna@yahoo.it. Hauptthemen laut MEDLINE: Anticonvulsants, Drug Resistant Epilepsy, Status Epilepticus. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Perampanel is a selective non-competitive antagonist of AMPA receptors, and the first agent of this class to become available for the treatment of epilepsy. It could be a useful tool for treatment of refractory status epilepticus (RSE). METHODS: We describe a series of eight RSE cases treated with Perampanel. RESULTS: Perampanel was successful in terminating SE in all the described cases. Only in one patient a severe psychomotor agitation occurred, but without needing PER discontinuation. No other adverse events were observed. CONSLUSION: Our case series of eight patients, albeit small, broadens the clinical experiences on the efficacy and safety of PER as a treatment for RSE. It may also support the early use of PER, considering the role of AMPA receptors in sustaining epileptic firing in SE. Further studies are warranted to clarify the potential of Perampanel in the treatment of status epilepticus and, in particular, in RSE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsDrug Resistant EpilepsyStatus EpilepticusHumansNitrilesPyridonesReceptors, AMPATreatment Outcome

Stichwörter der Autor:innen

EffectivenessPerampanelRefractory status epilepticusSafety

Substanzen

AnticonvulsantsNitrilesperampanelPyridonesReceptors, AMPA

Autor:innen und Institutionen

  • Neurological Clinic and Stroke Unit, "A. Cardarelli" Hospital, Naples, Italy. rosrenna@yahoo.it.
  • Neurological Clinic and Stroke Unit, "A. Cardarelli" Hospital, Naples, Italy.
  • Department of Neurosciences, AOU "San Giovanni di Dio e Ruggi d'Aragona", Salerno, Italy.

Zitieren

APA

Renna, R., Andreone, V., Barone, P., & Penza, P. (2025). Effectiveness and safety of Perampanel in refractory status epilepticus: a case series. Neurological Sciences. https://doi.org/10.1007/s10072-024-07798-w

Vancouver

Renna R, Andreone V, Barone P, Penza P. Effectiveness and safety of Perampanel in refractory status epilepticus: a case series. Neurological Sciences. 2025. doi:10.1007/s10072-024-07798-w

BibTeX
@article{Renna2025,
  author = {Renna, Rosaria and Andreone, Vincenzo and Barone, Paolo and Penza, Pietro},
  title = {Effectiveness and safety of Perampanel in refractory status epilepticus: a case series},
  journal = {Neurological Sciences},
  year = {2025},
  doi = {10.1007/s10072-024-07798-w}
}
Kostenlos starten →